Ayman Mukerji is a mindfulness-based therapist and New York University-based neuroimmunology researcher. She has several first-author scientific publications about the neurobiological effects of mindfulness and has authored a book chapter on brain changes in autism.

Ayman's story began in 2000 when she started meditating to cope with the stress of a traumatic personal experience. Her career on Wall Street at the time also flourished, and she became the youngest managing director of her company. Years later, Ayman realized she wanted to teach these simple mindfulness techniques, so she quit her Wall Street job to become a neuroimmunology researcher and enrolled in New York University’s clinical social work program. 

Ayman has several neuroscience papers on mindfulness interventions and book chapters on brain changes in autism spectrum disorder and epigenetic changes of mindfulness. She is doing a study with Harvard and Stanford universities to identify gut microbe markers of stress-induced diseases.

Ayman teaches mindfulness-based micro-habit programs for frontline caregivers—medical residents, faculty members, students, physicians, nurses, therapists, physical therapists, and administrative staff—at more than 25 US and Canadian hospitals. Her program teaches micro-habits that offer busy frontline caregivers stress management without the time commitment of meditation.